Mechanism of Action

GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a copper-containing tripeptide that appears to work through multiple molecular pathways, though the complete mechanistic picture remains under investigation.

Cellular Aging and Longevity Pathways
Recent research suggests GHK-Cu may influence fundamental aging processes at the cellular level. One study in Caenorhabditis elegans found that GHK-Cu delays aging through coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways (PMID: 42084774). The DAF-16 pathway is analogous to the human FOXO transcription factor pathway, which regulates stress response and longevity, while SKN-1 corresponds to human Nrf2, a key regulator of antioxidant responses.

Metabolic Regulation
The peptide demonstrates catalytic properties related to glucose metabolism. Research indicates GHK-Cu can activate cascade catalysis mechanisms that help regulate glucose levels and reverse hypoxia conditions, particularly in the context of infected diabetic wound healing (PMID: 42404628). This suggests the compound may influence cellular energy metabolism and oxygen utilization.

Antioxidant Activity
GHK-Cu exhibits laccase-like enzymatic properties, meaning it can catalyze oxidation reactions involving phenolic compounds (PMID: 42041438). This enzymatic activity may contribute to its antioxidant effects and ability to modulate oxidative stress responses in tissues.

Tissue Regeneration and Angiogenesis
The peptide appears to promote tissue repair through effects on both bone formation (osteogenesis) and blood vessel formation (angiogenesis). Research shows it can influence "osteogenic-angiogenic coupling responses" in certain biomaterial systems (PMID: 42320090), suggesting coordinated effects on multiple tissue types involved in healing.

Neurological Effects
In middle-aged mice, GHK-Cu administration showed behavioral rescue effects and influenced hippocampal aging programs, though the specific pathways varied depending on delivery method (intraperitoneal vs. intranasal) (PMID: 42245779).

Important Limitations
While these studies provide insights into potential mechanisms, much of the research is preclinical, conducted in cell cultures, animal models, or small organisms like C. elegans. The exact molecular targets and pathways in humans require further investigation through clinical trials. Currently, only limited clinical trial data is available, with most studies focusing on topical applications for skin conditions.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare providers for guidance on any therapeutic interventions.